Read + Share
Fuereder T, Minichsdorfer C, Mittlboeck M, Wagner C, et al. Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and
neck cancer: A prospective phase I/II study. Oral Oncol 2021;124:105634.
PMID: 34844042
|
 |
|
Fuereder T, Minichsdorfer C, Mittlboeck M, Wagner C, et al. Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and
neck cancer: A prospective phase I/II study. Oral Oncol 2021;124:105634.
PMID: 34844042
|
|
|
|